Sökresultat

Filtyp

Din sökning på "*" gav 565315 sökträffar

Tomas Jansson Group

Future medical imaging technology moves in the direction of molecular imaging where a contrast agent has been functionalized with tumor/tissue specific targeting agents (i.e. antibodies, affibodies, peptides, aptamers). Thus the contrast particle binds specifically to e.g. tumor tissue and can be enriched there. In other words, what is probed is the molecular abnormality that is the basis of the d

https://www.bme.lth.se/en/research/ultrasound/tomas-jansson-group - 2026-07-17

Biomedical Signal Processing

Electrical signals exist in many places in the human body, and are used for communication from and to the brain. They are employed to e.g. contract a muscle. We use computer simulations in order to better understand how the heart and other organs work, and to develop medical devices for diagnosis of, among others, heart disease. We combine expertise in signal processing and machine-learning method

https://www.bme.lth.se/en/research/biomedical-signal-processing - 2026-07-17

Pelle Ohlsson Group

We invent tomorrow’s microfluidic chips for medical diagnostics, biological research and agriculture, for instance finding bacteria in blood samples using ultrasound or crop pathogens in soil using AI-based image analysis. Finding bacteria in blood for sepsis diagnosticsSepsis is a systemic response to an infection and can be deadly. It is most often caused by bacteria, but concentrations of the c

https://www.bme.lth.se/en/research/nanobiotechnology-and-lab-chip/pelle-ohlsson-group - 2026-07-17

Engineering Health Annual Meeting_oldnarrow

September 21-22 The 2026 edition has a sustainability theme. Join us for two days of talks, activities, and poster presentations. Register here!   Program Monday September 21st10:00 Registration10:30 Welcome Address10:45 Keynote Speaker Martina Kvist Reimer (industry/Region Skåne):Connecting the Dots: A Systems View on Sustainability in Life Science research11:30 Workshop/discussion12:00 Lunch13:3

https://www.bme.lth.se/en/engineering-health-annual-meetingoldnarrow - 2026-07-17

Biological mass spectrometry

Biological mass spectrometry is an important tool in modern biomedical research, providing detailed insights into the molecular composition of cells, tissues, and biofluids. Through sensitive and large-scale analysis of proteins and small molecules, mass spectrometry (MS) contributes to understanding biological processes and disease mechanisms beyond what can be inferred from genomic data alone. O

https://www.bme.lth.se/en/research/biological-mass-spectrometry - 2026-07-17

Biomedical Ultrasound

The first clinical application of ultrasound for diagnostic purposes was developed in Lund in 1953, when the physicist Hellmuth Hertz and the cardiologist Inge Edler were the first to analyze the motion of heart valves. Since then, the technology has undergone extensive development and is now the most widely used imaging modality in healthcare. Our group conducts research, develops, and evaluates

https://www.bme.lth.se/en/research/ultrasound/biomedical-ultrasound - 2026-07-17

Nanobiotechnology and Lab-on-a-chip

We develop technology to manipulate and study cells and organisms. These miniaturized tools have a range of applications in cancer diagnostics, blood transfusions, fungal studies, and neurobiology. Many of our activities fall within the research field of acoustofluidics where ultrasound generates forces on cells or nanoparticles inside microchannel networks. These systems can sort out specific sub

https://www.bme.lth.se/en/research/nanobiotechnology-and-lab-chip - 2026-07-17

DXA2FEM

In the first panel on the left, the patient is scanned in an X-ray machine, generating a two-dimensional image, second panel. Our tool, DXA2FEM, then recreates a three-dimensional image in panel three, which enables accurate fracture assessment.Osteoporosis is defined as low bone mass, and results in a markedly increased risk of skeletal fractures. Development of new drugs to reduce bone loss or i

https://www.bme.lth.se/en/research/biomechanics/dxa2fem - 2026-07-17

Engineering Health Annual Meeting 2026

Register here!   Program Monday September 21st10:00 Registration10:30 Welcome Address10:45 Keynote Speaker Martina Kvist Reimer (industry/Region Skåne):Connecting the Dots: A Systems View on Sustainability in Life Science research11:30 Workshop/discussion12:00 Lunch13:30 Invited Talks (10 min + 5 min Q&A)14:45 Coffee Break15:15 Pitch presentations (3 Minutes)15:45 Poster Session19:00 Dinner (with

https://www.bme.lth.se/en/engineering-health-annual-meeting-2026 - 2026-07-17

Ultrasound

Since the pioneering work of Hellmuth Hertz and Inge Edler, our research groups have carried out research in ultrasound, with applications in medicine and biology. Today we focus on Arterial wall motion, Biosonar, Diagnosis of Hirschsprung’s disease, Magnetomotive ultrasound imaging, Photoacoustic imaging, and Plaque characterization. Researcher Profiles The links will open in the Lund University

https://www.bme.lth.se/en/research/ultrasound - 2026-07-17

Medicinteknik i Skåne 2026

19 November 2026 08:00 to 15:30 | Conference Med seminariedagen Medicinteknik i Skåne vill vi ge deltagarna möjligheter att skapa kontaktytor och få kunskap om medicinteknisk forskning och utveckling i regionen. Konferensen riktar sig till aktörer inom akademi, sjukvård och företag. Konferensen syftar även till en ökad förståelse för dessa olika aktörers problemställningar samt utbyte av idéer. Ar

https://www.bme.lth.se/en/calendar/medicinteknik-i-skane-2026 - 2026-07-17

Neuroengineering

Our research is mainly focusing on the following areas: neuromuscular control, neuromuscular modelling, muscle-machine interface, human-machine interfaces, sensors and haptics. We employ machine/deep learning models to create state of the art human machine interfaces based on signals derived from muscles and the brain. We use signal processing techniques to unravel how motor neurons are recruited

https://www.bme.lth.se/en/research/neuroengineering - 2026-07-17